It is unclear what the company intends to charge for the vials, the report said. Unlike Novo, Eli Lilly and Company already sells its obesity drug Zepbound in both injector pen and vial formats. Novo ...
The price of the popular GLP-1 medications will be cut, starting in January of 2027, manufacturer Novo Nordisk said in a statement Tuesday, Feb. 24 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results